Strategic Blueprint LLC Sells 361 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Strategic Blueprint LLC cut its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 28.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 916 shares of the biotechnology company’s stock after selling 361 shares during the period. Strategic Blueprint LLC’s holdings in Axon Enterprise were worth $544,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Geode Capital Management LLC lifted its position in shares of Axon Enterprise by 2.0% during the 3rd quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company’s stock valued at $710,103,000 after buying an additional 35,320 shares in the last quarter. Westfield Capital Management Co. LP lifted its holdings in Axon Enterprise by 12.2% during the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after purchasing an additional 127,769 shares in the last quarter. Champlain Investment Partners LLC increased its stake in shares of Axon Enterprise by 13.9% in the third quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock worth $272,695,000 after purchasing an additional 83,265 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Axon Enterprise by 1.6% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock valued at $224,281,000 after purchasing an additional 9,090 shares during the period. Finally, Groupama Asset Managment purchased a new position in shares of Axon Enterprise during the 3rd quarter valued at $200,000. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Down 0.2 %

Shares of NASDAQ:AXON opened at $652.18 on Friday. The company has a market cap of $49.73 billion, a price-to-earnings ratio of 168.52, a PEG ratio of 6.41 and a beta of 1.04. Axon Enterprise, Inc. has a 12 month low of $247.04 and a 12 month high of $698.67. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The company has a 50-day moving average price of $619.63 and a 200 day moving average price of $481.39.

Wall Street Analysts Forecast Growth

A number of research firms have commented on AXON. Needham & Company LLC raised their price target on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a report on Friday, November 8th. JMP Securities lifted their target price on Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research note on Thursday, October 31st. Northland Securities increased their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. Finally, TD Cowen assumed coverage on shares of Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 target price for the company. One research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $524.85.

Insider Activity

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the sale, the director now owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Jeffrey C. Kunins sold 21,834 shares of the firm’s stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the completion of the sale, the insider now owns 154,394 shares of the company’s stock, valued at $91,691,508.72. This trade represents a 12.39 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 50,545 shares of company stock valued at $30,721,337 in the last ninety days. Insiders own 6.10% of the company’s stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.